Format

Send to

Choose Destination
J Am Acad Dermatol. 2012 Dec;67(6):1210-3. doi: 10.1016/j.jaad.2012.03.009. Epub 2012 Apr 18.

Topical propranolol for treatment of superficial infantile hemangiomas.

Author information

1
Department of Aesthetic Plastic, and Burn Surgery, Shandong Provincial Hospital, Shandong University, Jinan, China.

Abstract

BACKGROUND:

"Wait-and-see" is a common principle for most superficial infantile hemangiomas (IHs) because of their expected involution. Topical propranolol has recently been reported to be an effective treatment for superficial IHs.

OBJECTIVE:

The aim of this study was to evaluate the efficacy and safety of 1% propranolol ointment in the treatment of superficial IHs.

METHODS:

A retrospective chart review was performed on 25 children (21 female and 4 male) with a median age of 4 months (range, 1-10 months). A total of 28 lesions were treated with 1% propranolol ointment. Topical propranolol was applied thrice daily for a mean duration of 21 weeks (range, 5-59 weeks). Changes in the size, texture, and color of the tumor were monitored and recorded at regular intervals. The treatment response was evaluated using a 3-point scale system: good, partial, and no response. Adverse effects after medication were evaluated and managed accordingly.

RESULTS:

Of the 28 hemangiomas, 16 (57%) demonstrated good response, 9 (33%) showed a partial response, and 3 (10%) had no response. Among all the IHs, 90% showed either good or partial responses to topical 1% propranolol ointment treatment. No systemic complication was observed in any of the patients.

LIMITATIONS:

This report is a retrospective uncontrolled study.

CONCLUSIONS:

Topical therapy with 1% propranolol ointment may be a safe and effective method for the treatment of superficial IHs and can be used as an adjuvant treatment measure during the wait-and-see period.

PMID:
22516113
DOI:
10.1016/j.jaad.2012.03.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center